TR200001263T2 - Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri - Google Patents

Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri

Info

Publication number
TR200001263T2
TR200001263T2 TR2000/01263T TR200001263T TR200001263T2 TR 200001263 T2 TR200001263 T2 TR 200001263T2 TR 2000/01263 T TR2000/01263 T TR 2000/01263T TR 200001263 T TR200001263 T TR 200001263T TR 200001263 T2 TR200001263 T2 TR 200001263T2
Authority
TR
Turkey
Prior art keywords
therapeutics
diagnosis
respiratory disease
chronic obstructive
obstructive respiratory
Prior art date
Application number
TR2000/01263T
Other languages
English (en)
Inventor
W. Duff Gordon
Giovine Marco
J. Barnes Peter
Lim Simon
Original Assignee
Interleukin Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics, Inc. filed Critical Interleukin Genetics, Inc.
Publication of TR200001263T2 publication Critical patent/TR200001263T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir subjenin kronik tikayici bir solunum yolu hastaligi gelistirme konusunda süpheli oldugunu önceden haber veren polimorfizim taramasina yönelik metot ve kitler ve ayni zamanda da hastaligin nispi ciddiyeti tarif edilmektedir.
TR2000/01263T 1997-11-07 1998-11-09 Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri TR200001263T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma

Publications (1)

Publication Number Publication Date
TR200001263T2 true TR200001263T2 (tr) 2000-12-21

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01263T TR200001263T2 (tr) 1997-11-07 1998-11-09 Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri

Country Status (13)

Country Link
EP (1) EP1029079B1 (tr)
JP (1) JP2001522586A (tr)
AT (1) ATE383438T1 (tr)
AU (1) AU760856B2 (tr)
BR (1) BR9813950A (tr)
CA (1) CA2308570A1 (tr)
ES (1) ES2297900T3 (tr)
HU (1) HUP0301197A2 (tr)
IL (1) IL135957A0 (tr)
NO (1) NO20002176L (tr)
PL (1) PL340624A1 (tr)
TR (1) TR200001263T2 (tr)
WO (1) WO1999024615A2 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
CA2367294A1 (en) * 1999-04-02 2000-10-12 Interleukin Genetics, Inc. Prediction of risk of interstitial lung disease
AU7706000A (en) * 1999-09-22 2001-04-24 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
WO2005019259A2 (en) * 2003-08-25 2005-03-03 Compugen Ltd. Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
JP2001522586A (ja) 2001-11-20
IL135957A0 (en) 2001-05-20
WO1999024615A3 (en) 1999-09-16
CA2308570A1 (en) 1999-05-20
PL340624A1 (en) 2001-02-12
ES2297900T3 (es) 2008-05-01
AU1386399A (en) 1999-05-31
HUP0301197A2 (hu) 2003-07-28
NO20002176L (no) 2000-07-05
BR9813950A (pt) 2000-09-26
EP1029079A2 (en) 2000-08-23
ATE383438T1 (de) 2008-01-15
AU760856B2 (en) 2003-05-22
WO1999024615A2 (en) 1999-05-20
NO20002176D0 (no) 2000-04-27
EP1029079B1 (en) 2008-01-09

Similar Documents

Publication Publication Date Title
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
ATE524196T1 (de) An das krebsassoziierte antigen cd46 bindende antikörper und verwendungsverfahren dafür
HUP0001020A2 (hu) Sztanolkészítmény és annak felhasználása
NL194519B (nl) Akoestische sonde voor boorgatonderzoek.
KR970701790A (ko) Mage 유전자 발현에 의한 암상태의 결정(determination of cancerous conditions by mage gene expression)
WO2002056749A3 (en) Diagnostic and monitoring methods for cancer
DE60322848D1 (de) System für kontinuierliche leistungstests
ATE317451T1 (de) Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs
TR200001263T2 (tr) Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri
ATE476662T1 (de) Diagnoseverfahren
ES2131929T3 (es) Procedimiento ultrasensible para la determinacion de la troponina i cardiaca.
ATE352311T1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
WO2003087761A3 (en) Molecular profiling of disease and therapeutic response using phospho-specific antibodies
MX9606584A (es) Biosensores sensibles a masas.
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DE50012513D1 (de) Entwickler für bestrahlte, strahlungsempfindliche Aufzeichnungsmaterialien
DE69132420D1 (de) Zusammensetzung zur immunologischen analyse und ihr herstellungsverfahren unter verwendung von antigen, sowie immunologische diagnosekits für die chagas-krankheit
ES2311459T3 (es) Diagnostico de restenosis.
ATE235054T1 (de) Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
EP1097944A4 (en) ANTIBODIES AGAINST INTRACELLULAR DOMAINS OF PROTEIN TYROSIN PHOSPHATASE
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
ES2151118T3 (es) Evaluacion de substancias para aumentar y para modificar la actividad para la apc.
DE29707771U1 (de) Einrichtung zur Bestimmung von endexpiratorischen Gasen, insbes. für die Ovulationszeitpunktbestimmung